171 related articles for article (PubMed ID: 29210627)
1. Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection.
Yong CL; Gathe JC; Knecht G; Orrell C; Mallolas J; Podzamczer D; Trottier B; Zhang W; Sabo JP; Vinisko R; Drulak M; Quinson AM
HIV Clin Trials; 2017; 18(5-6):189-195. PubMed ID: 29210627
[TBL] [Abstract][Full Text] [Related]
2. Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over study.
Giaquinto C; Anab
